Access to and use of high blood pressure medications in Brazil

Detalhes bibliográficos
Autor(a) principal: Mengue,Sotero Serrate
Data de Publicação: 2016
Outros Autores: Bertoldi,Andréa Dâmaso, Ramos,Luiz Roberto, Farias,Mareni Rocha, Oliveira,Maria Auxiliadora, Tavares,Noemia Urruth Leão, Arrais,Paulo Sergio Dourado, Luiza,Vera Lucia, Pizzol,Tatiane da Silva Dal
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista de Saúde Pública
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102016000300305
Resumo: ABSTRACT OBJECTIVE To analyze the access to and use of medicines for high blood pressure among the Brazilian population according to social and demographic conditions. METHODS Analysis of data from Pesquisa Nacional Sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines), a nationwide cross-sectional, population-based study, with probability sampling, carried out between September 2013 and February 2014 in urban households in the five Brazilian regions. The study evaluated the access and use of medicines to treat people with high blood pressure. The independent variables were gender, age, socioeconomic status and Brazilian region. The study also described the most commonly used drugs and the percentage of people treated with one, two, three or more drugs. Point estimations and confidence intervals were calculated considering the sample weights and sample complex plan. RESULTS Prevalence of high blood pressure was 23.7% (95%CI 22.8–24.6). Regarding people with this condition, 93.8% (95%CI 92.8–94.8) had indication for drug therapy and, of those, 94.6% (95%CI 93.5–95.5) were using the medication at the time of interview. Full access to medicines was 97.9% (95%CI 97.3–98.4); partial access, 1.9% (95%CI 1.4–2.4); and no access, 0.2% (95%CI 0.1–0.4). The medication used to treat high blood pressure, 56.0% (95%CI 52.6–59.2) were obtained from SUS (Brazilian Unified Health System), 16.0% (95%CI 14.3–17.9) from Popular Pharmacy Program, 25.7% (95%CI 23.4–28.2) were paid for by the patients themselves and 2.3% (95%CI 1.8–2.9) were obtained from other locations. The five most commonly used drugs were, in descending order, hydrochlorothiazide, losartan, captopril, enalapril and atenolol. Of the total number of patients on treatment, 36.1% (95%CI 34.1–37.1) were using two medicines and 13.5% (95%CI 12.3–14.9) used three or more. CONCLUSIONS Access to medicines for the treatment of high blood pressure may be considered high and many of them are available free of charge. The most commonly used drugs are among those recommended as first-line treatment for high blood pressure control. The percentage of people using more than one drug seems to follow the behavior observed in other countries.
id USP-23_941dbf013e384550c3a8edc1673f585e
oai_identifier_str oai:scielo:S0034-89102016000300305
network_acronym_str USP-23
network_name_str Revista de Saúde Pública
repository_id_str
spelling Access to and use of high blood pressure medications in BrazilAntihypertensive Agents, supply & distributionDrug UtilizationDrugs of Continuous UseHealth Services AccessibilitySocioeconomic FactorsHealth SurveysABSTRACT OBJECTIVE To analyze the access to and use of medicines for high blood pressure among the Brazilian population according to social and demographic conditions. METHODS Analysis of data from Pesquisa Nacional Sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines), a nationwide cross-sectional, population-based study, with probability sampling, carried out between September 2013 and February 2014 in urban households in the five Brazilian regions. The study evaluated the access and use of medicines to treat people with high blood pressure. The independent variables were gender, age, socioeconomic status and Brazilian region. The study also described the most commonly used drugs and the percentage of people treated with one, two, three or more drugs. Point estimations and confidence intervals were calculated considering the sample weights and sample complex plan. RESULTS Prevalence of high blood pressure was 23.7% (95%CI 22.8–24.6). Regarding people with this condition, 93.8% (95%CI 92.8–94.8) had indication for drug therapy and, of those, 94.6% (95%CI 93.5–95.5) were using the medication at the time of interview. Full access to medicines was 97.9% (95%CI 97.3–98.4); partial access, 1.9% (95%CI 1.4–2.4); and no access, 0.2% (95%CI 0.1–0.4). The medication used to treat high blood pressure, 56.0% (95%CI 52.6–59.2) were obtained from SUS (Brazilian Unified Health System), 16.0% (95%CI 14.3–17.9) from Popular Pharmacy Program, 25.7% (95%CI 23.4–28.2) were paid for by the patients themselves and 2.3% (95%CI 1.8–2.9) were obtained from other locations. The five most commonly used drugs were, in descending order, hydrochlorothiazide, losartan, captopril, enalapril and atenolol. Of the total number of patients on treatment, 36.1% (95%CI 34.1–37.1) were using two medicines and 13.5% (95%CI 12.3–14.9) used three or more. CONCLUSIONS Access to medicines for the treatment of high blood pressure may be considered high and many of them are available free of charge. The most commonly used drugs are among those recommended as first-line treatment for high blood pressure control. The percentage of people using more than one drug seems to follow the behavior observed in other countries.Faculdade de Saúde Pública da Universidade de São Paulo2016-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102016000300305Revista de Saúde Pública v.50 suppl.2 2016reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USP10.1590/s1518-8787.2016050006154info:eu-repo/semantics/openAccessMengue,Sotero SerrateBertoldi,Andréa DâmasoRamos,Luiz RobertoFarias,Mareni RochaOliveira,Maria AuxiliadoraTavares,Noemia Urruth LeãoArrais,Paulo Sergio DouradoLuiza,Vera LuciaPizzol,Tatiane da Silva Daleng2017-02-13T00:00:00Zoai:scielo:S0034-89102016000300305Revistahttp://www.scielo.br/scielo.php?script=sci_serial&pid=0034-8910&lng=pt&nrm=isoONGhttps://old.scielo.br/oai/scielo-oai.phprevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2017-02-13T00:00Revista de Saúde Pública - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Access to and use of high blood pressure medications in Brazil
title Access to and use of high blood pressure medications in Brazil
spellingShingle Access to and use of high blood pressure medications in Brazil
Mengue,Sotero Serrate
Antihypertensive Agents, supply & distribution
Drug Utilization
Drugs of Continuous Use
Health Services Accessibility
Socioeconomic Factors
Health Surveys
title_short Access to and use of high blood pressure medications in Brazil
title_full Access to and use of high blood pressure medications in Brazil
title_fullStr Access to and use of high blood pressure medications in Brazil
title_full_unstemmed Access to and use of high blood pressure medications in Brazil
title_sort Access to and use of high blood pressure medications in Brazil
author Mengue,Sotero Serrate
author_facet Mengue,Sotero Serrate
Bertoldi,Andréa Dâmaso
Ramos,Luiz Roberto
Farias,Mareni Rocha
Oliveira,Maria Auxiliadora
Tavares,Noemia Urruth Leão
Arrais,Paulo Sergio Dourado
Luiza,Vera Lucia
Pizzol,Tatiane da Silva Dal
author_role author
author2 Bertoldi,Andréa Dâmaso
Ramos,Luiz Roberto
Farias,Mareni Rocha
Oliveira,Maria Auxiliadora
Tavares,Noemia Urruth Leão
Arrais,Paulo Sergio Dourado
Luiza,Vera Lucia
Pizzol,Tatiane da Silva Dal
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Mengue,Sotero Serrate
Bertoldi,Andréa Dâmaso
Ramos,Luiz Roberto
Farias,Mareni Rocha
Oliveira,Maria Auxiliadora
Tavares,Noemia Urruth Leão
Arrais,Paulo Sergio Dourado
Luiza,Vera Lucia
Pizzol,Tatiane da Silva Dal
dc.subject.por.fl_str_mv Antihypertensive Agents, supply & distribution
Drug Utilization
Drugs of Continuous Use
Health Services Accessibility
Socioeconomic Factors
Health Surveys
topic Antihypertensive Agents, supply & distribution
Drug Utilization
Drugs of Continuous Use
Health Services Accessibility
Socioeconomic Factors
Health Surveys
description ABSTRACT OBJECTIVE To analyze the access to and use of medicines for high blood pressure among the Brazilian population according to social and demographic conditions. METHODS Analysis of data from Pesquisa Nacional Sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines), a nationwide cross-sectional, population-based study, with probability sampling, carried out between September 2013 and February 2014 in urban households in the five Brazilian regions. The study evaluated the access and use of medicines to treat people with high blood pressure. The independent variables were gender, age, socioeconomic status and Brazilian region. The study also described the most commonly used drugs and the percentage of people treated with one, two, three or more drugs. Point estimations and confidence intervals were calculated considering the sample weights and sample complex plan. RESULTS Prevalence of high blood pressure was 23.7% (95%CI 22.8–24.6). Regarding people with this condition, 93.8% (95%CI 92.8–94.8) had indication for drug therapy and, of those, 94.6% (95%CI 93.5–95.5) were using the medication at the time of interview. Full access to medicines was 97.9% (95%CI 97.3–98.4); partial access, 1.9% (95%CI 1.4–2.4); and no access, 0.2% (95%CI 0.1–0.4). The medication used to treat high blood pressure, 56.0% (95%CI 52.6–59.2) were obtained from SUS (Brazilian Unified Health System), 16.0% (95%CI 14.3–17.9) from Popular Pharmacy Program, 25.7% (95%CI 23.4–28.2) were paid for by the patients themselves and 2.3% (95%CI 1.8–2.9) were obtained from other locations. The five most commonly used drugs were, in descending order, hydrochlorothiazide, losartan, captopril, enalapril and atenolol. Of the total number of patients on treatment, 36.1% (95%CI 34.1–37.1) were using two medicines and 13.5% (95%CI 12.3–14.9) used three or more. CONCLUSIONS Access to medicines for the treatment of high blood pressure may be considered high and many of them are available free of charge. The most commonly used drugs are among those recommended as first-line treatment for high blood pressure control. The percentage of people using more than one drug seems to follow the behavior observed in other countries.
publishDate 2016
dc.date.none.fl_str_mv 2016-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102016000300305
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102016000300305
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/s1518-8787.2016050006154
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Faculdade de Saúde Pública da Universidade de São Paulo
publisher.none.fl_str_mv Faculdade de Saúde Pública da Universidade de São Paulo
dc.source.none.fl_str_mv Revista de Saúde Pública v.50 suppl.2 2016
reponame:Revista de Saúde Pública
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Revista de Saúde Pública
collection Revista de Saúde Pública
repository.name.fl_str_mv Revista de Saúde Pública - Universidade de São Paulo (USP)
repository.mail.fl_str_mv revsp@org.usp.br||revsp1@usp.br
_version_ 1748936503764975616